Qualigen Therapeutics, Inc.
QLGN
$3.11
$0.103.32%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.28% | -91.15% | -97.86% | -87.31% | -68.66% |
| Total Receivables | 451.44% | -- | -- | -- | -60.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -45.03% | -67.17% | -63.81% | -44.03% | -32.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 3,588.52% | -- | -- |
| Total Current Assets | -32.95% | -89.01% | -86.69% | -89.22% | -66.82% |
|
|
|||||
| Total Current Assets | -32.95% | -89.01% | -86.69% | -89.22% | -66.82% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -89.48% | 3,510.42% |
| Total Assets | -46.41% | -95.94% | -93.70% | -89.35% | -81.20% |
|
|
|||||
| Total Accounts Payable | 4.24% | 5.56% | 100.17% | 258.78% | 163.72% |
| Total Accrued Expenses | -55.33% | -53.29% | -55.60% | -35.52% | 24.29% |
| Short-term Debt | 72.36% | -6.05% | -32.58% | 2,058.14% | -11.60% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -64.31% | -86.76% | -76.34% | -99.10% | 7.54% |
| Total Other Current Liabilities | -64.31% | -86.76% | -76.34% | -99.10% | 7.54% |
| Total Current Liabilities | -25.23% | -43.34% | -45.12% | -51.94% | 22.03% |
|
|
|||||
| Total Current Liabilities | -25.23% | -43.34% | -45.12% | -51.94% | 22.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 72.36% | -6.05% | -32.58% | 2,058.14% | -11.60% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.23% | -51.10% | -53.42% | -59.90% | -15.43% |
|
|
|||||
| Common Stock & APIC | 6.52% | 3.14% | 3.02% | 3.73% | 3.40% |
| Retained Earnings | -6.87% | -8.78% | -10.82% | -12.98% | -17.87% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -30.49% | -310.31% | -172.32% | -129.07% | -113.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.49% | -310.31% | -172.32% | -129.07% | -113.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.49% | -229.32% | -156.80% | -124.00% | -110.31% |
|
|
|||||
